Journal of Clinical Toxicology
Open Access
ISSN: 2161-0495
+44 1478 350008
ISSN: 2161-0495
+44 1478 350008
Randall L Davis
Associate Professor, Department of Pharmacology and Physiology
Oklahoma State University,
Dr. Davis received his BS in biomedical sciences from Oklahoma State University in 1990. He remained at Oklahoma State University until 1994 when he received a MS in Zoology. Dr. Davis then earned a PhD in nutrition from Texas Tech University in 1998. Upon completion of his doctoral degree he trained for six years 1998 to 2004 in Pharmacology and Neuroscience as a Postdoctoral Research Associate at the Texas Tech University Health Sciences Center and was an Instructor and course coordinator in the nutrition program at Texas Tech University. During this period he received a National Research Service Award from the National Institutes of Health. Additionally during these training years he received numerous academic scholarships teaching awards and young investigator awards. In 2004 Dr. Davis was appointed Assistant Professor of Pharmacology at the Oklahoma State University Center for Health Sciences OSUCHS in Tulsa OK. Then in 2010, Dr. Davis was promoted to Associate Professor with tenure at OSUCHS. Dr. Davis has served as the Managing Editor for the special issue: Neuroinflammation: modulation by drugs of abuse published in Frontiers in Bioscience and is the Editor-in-Chief of the International Journal of Cytokine Mediator Research. Dr. Davis peer reviews manuscripts for numerous scientific journals and has served as an ad hoc reviewer for the National Institutes of Health Alzheimer’s Association and Kentucky Tobacco Research Development Center. In addition to his teaching responsibilities in the Medical and Biomedical Sciences Graduate curricula at OSUCHS and other professional activities. Dr. Davis research lab is interested in the role of neuroinflammation in neuropathologies including neuroAIDS parkinson’s disease and autism. In particular his research efforts are focused largely on 1. understanding the effects of alcohol abuse on inflammatory signaling in human astroglial cells 2. characterizing the novel antiinflammatory actions of opioid compounds and 3. understanding the effects of heavy metals exposure on neuroimmune signaling.
Dr. Davis’s research lab is interested in the role of neuroinflammation in neuropathologies including neuroAIDS, parkinson’s disease and autism. In particular, his research efforts are focused largely on 1) understanding the effects of alcohol abuse on inflammatory signaling in human astroglial cells, 2) characterizing the novel, anti-inflammatory actions of opioid compounds and 3) understanding the effects of heavy metals exposure on neuroimmune signaling.